Nkarta (NKTX) Treasury Shares (2022 - 2026)

Nkarta's quarterly Treasury Shares came in at $1.0 million in Q1 2026, up 17.71% year-on-year from $854884.0 in Q1 2025, and up 55.06% quarter-over-quarter from $648959.0 in Q4 2025.

Nkarta has reported Treasury Shares for 5 years, with the latest figure at $1.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Treasury Shares rose 17.71% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 17.71% YoY), and the FY2025 full-year result was $648959.0, down 44.43% from the prior year.
  • Treasury Shares for Q1 2026 stood at $1.0 million, up from $648959.0 in the prior quarter.
  • The five-year high for Treasury Shares was $1.2 million in Q1 2024, with the low at $229418.0 in Q1 2022.
  • Average Treasury Shares over 5 years is $755077.1, with a median of $716956.0 recorded in 2023.
  • Year-over-year, Treasury Shares soared 248.68% in 2023 and sank 44.43% in 2025.
  • Tracing NKTX's Treasury Shares over 5 years: stood at $356728.0 in 2022, then soared by 66.73% to $594768.0 in 2023, then jumped by 96.36% to $1.2 million in 2024, then slumped by 44.43% to $648959.0 in 2025, then jumped by 55.06% to $1.0 million in 2026.
  • The last three Treasury Shares figures came in at $1.0 million (Q1 2026), $648959.0 (Q4 2025), and $661636.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 265,401.92
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 700,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 34.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Nkarta 232.80 Mn 232.80 Mn - 1.01 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.01 Mn
Mar 31, 2026 1.01 Mn
Dec 31, 2025 648,959.00
Dec 31, 2025 648,959.00
Sep 30, 2025 661,636.00
Sep 30, 2025 661,636.00
Jun 30, 2025 832,299.00
Jun 30, 2025 832,299.00
Mar 31, 2025 854,884.00
Mar 31, 2025 854,884.00
Dec 31, 2024 1.17 Mn
Dec 31, 2024 1.17 Mn
Sep 30, 2024 1.18 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.19 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 1.22 Mn
Mar 31, 2024 1.22 Mn
Dec 31, 2023 594,768.00
Dec 31, 2023 594,768.00
Sep 30, 2023 695,110.00
Sep 30, 2023 695,110.00
Jun 30, 2023 716,956.00
Jun 30, 2023 716,956.00
Mar 31, 2023 799,930.00
Mar 31, 2023 799,930.00
Dec 31, 2022 356,728.00
Dec 31, 2022 356,728.00
Sep 30, 2022 359,708.00
Sep 30, 2022 359,708.00
Jun 30, 2022 320,278.00
Jun 30, 2022 320,278.00
Mar 31, 2022 229,418.00
Mar 31, 2022 229,418.00